GlassScriptPhysician profile
Amber Coffman
NPI 1306398607
$7,439.33
in general payments reported to CMS, 2019-2025
23 companies · $1,924 in 2025
The $1,924 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $473 · 2022: $1,240 · 2023: $1,279 · 2024: $2,523 · 2025: $1,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,573 · Travel and Lodging: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,572.79 |
| Travel and Lodging | $1,152.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,041.32 | 2022-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Cvrx, INC. | $1,566.03 | 2022-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $550.66 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $373.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $359.86 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $318.56 | 2021-2025 | Farxiga, Wainua |
| Amgen INC. | $304.76 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $298.88 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $289.33 | 2024-2025 | Onpattro, Amvuttra |
| Philips North America LLC | $281.40 | 2022-2025 | (Ck7) Extended Holter, (Ck6) Holter, Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.64 | 2022-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $171.08 | 2023-2024 | Inpefa |
| Stryker Corporation | $121.75 | 2025 | Flowtriever |
| Actelion Pharmaceuticals US, INC. | $120.50 | 2024-2025 | Uptravi, Opsumit |
| Abbott Laboratories | $116.48 | 2021-2025 | Aveir |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $86.28 | 2022-2023 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.10 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $59.47 | 2024-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $44.39 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $19.71 | 2022 | |
| Medtronic, INC. | $16.96 | 2022 | |
| Glaxosmithkline, LLC. | $16.24 | 2025 | Arexvy, Shingrix |
| Medicomp INC | $14.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Coffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.